Congressional investigations pose high-stakes legal, business and reputational challenges, often amid intense media scrutiny and political pressure. Our team brings together former senior congressional staff, federal prosecutors, government officials, litigators and white-collar defense attorneys with firsthand experience working with key committees and advising businesses, executives and public officials throughout the investigative process.
We develop investigation-response strategies, respond to subpoenas and document demands, and work directly with committee staff to clarify and narrow requests while protecting privileged and sensitive information and business interests. We also prepare executives and other witnesses for transcribed interviews and public hearings, manage parallel civil, regulatory and criminal investigations, and provide strategic communications guidance to address media scrutiny, minimize disruption and protect clients’ reputations.
Our government experience includes former leadership and enforcement roles at the U.S. Senate Judiciary Committee, the Department of Justice, the U.S. Attorney’s Office for the Southern District of New York, the Securities and Exchange Commission, and the Treasury Department’s Office of Foreign Assets Control. This background informs our practical guidance on legal exposure, business disruption and reputational risk.
Our Experience
Pharmaceutical and biologic manufacturers: Represented leading manufacturers in congressional investigations and testimony concerning prescription biologics, nonsteroidal pain medications, diet drugs, statins and other products, alongside related class actions, multidistrict litigation, criminal proceedings and shareholder derivative matters.
Multinational technology company: Represented a multinational technology company in a congressional investigation and subsequent constitutional litigation challenging unprecedented government-wide debarment and suspension actions.
Estate of Jeffrey Epstein: Representing the co-executor of the estate in the House Committee on Oversight and Government Reform’s ongoing investigation into Epstein-related matters.
Phillips Auctioneers: Represented Phillips in the U.S. Senate Permanent Subcommittee on Investigations’ inquiry into money laundering risks in the art market.
Latest Updates
Preparing Life Sciences Companies for Post-Election Investigations
Prescription drug pricing will likely become a prominent focus of Congressional oversight with Democrats taking control of Congress next year.
Betting on Washington: Prediction Markets and Congressional Scrutiny After the Midterms
With Democrats set to control both chambers of Congress this upcoming January, investigative priorities are sure to change, but prediction- and betting-market operators don’t need to wait for the new Congress to be seated to prepare for that shift.
Jeremy Paner Discusses Sanctions Complexities Surrounding Russian Diesel Imports with BBC and Fox News
Speaking to the BBC and Fox News, Jeremy Paner discussed the sanctions complexities surrounding Russian diesel shipments bound for the U.S. and the potential legal risk to companies involved in related transactions.
Stay Up to Date
Sign up to receive practical updates, fresh perspectives and helpful guidance delivered straight to your inbox.
Stay connected for our latest news and insights.